Ivermectin in Peru – results that save lives
Interview and article by Christine Clark Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as… read more.
Interview and article by Christine Clark Dr David Scheim explains how the original analysis factored out confounders and showed a 74% reduction in deaths at 30 days as… read more.
Interview and article by Christine Clark Further analysis of results from Peru has now shown that systematic treatment of the population for covid-19 with ivermectin resulted in a… read more.
The Medicines Health Regulatory Authority (MHRA) and European Medicines Agency (EMA) reaffirmed the benefits of COVID-19 Vaccine AstraZeneca continue to far outweigh the risks.
Johnson & Johnson welcomes the interim recommendation by the Strategic Advisory Group of Experts (SAGE) on Immunization for the World Health Organization (WHO) supporting the use of Johnson… read more.
Johnson & Johnson announced that the European Commission (EC) has granted a Conditional Marketing Authorization (CMA) for its single-dose COVID-19 vaccine JNJ 78436735, developed by the Janssen Pharmaceutical… read more.
Health Canada has approved the Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19) and a related shot by the Serum Institute of India for use in Canada.
Following a recent concern raised around thrombotic events, AstraZeneca would like to offer its reassurance on the safety of its COVID-19 vaccine based on clear scientific evidence. Safety… read more.
Article written by Gary Finnegan. The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended six medicines for approval at its February 2021 meeting:
Article written by Gary Finnegan. Regulators around the globe are aligning their approaches to the approval of vaccines and medicines against COVID-19. Closer cooperation is seen as crucial… read more.
Interview and article by Christine Clark In the first ten years of the UK national HPV vaccination programme more than ten million doses of HPV vaccine were given… read more.
Article written by Gary Finnegan. New COVID-19 vaccines against variants of the virus could be approved much more quickly than the first generation of jabs. The European Medicines… read more.
Gilead Sciences, Inc. announced new, long-term data from open-label extensions (OLE) of two Phase III studies (Study 1489 and Study 1490) of Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.